Literature DB >> 17631217

Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.

Shajil Chalil1, Berthold Stegemann, Sarkaw Muhyaldeen, Kayvan Khadjooi, Russell E A Smith, Paul J Jordan, Francisco Leyva.   

Abstract

OBJECTIVES: We aimed to assess a novel measure of left ventricular (LV) dyssynchrony, a cardiovascular magnetic resonance-tissue synchronization index (CMR-TSI), in patients with heart failure (HF). A further aim was to determine whether CMR-TSI predicts mortality and major cardiovascular events (MCE) after cardiac resynchronization therapy (CRT).
BACKGROUND: Cardiac dyssynchrony is a predictor of mortality in patients with HF. The unparalleled spatial resolution of CMR may render CMR-TSI a predictor of clinical benefit after CRT.
METHODS: In substudy A, CMR-TSI was assessed in 66 patients with HF (age 60.8 +/- 10.8 years, LV ejection fraction 23.9 +/- 12.1% [mean +/- SD]) and 20 age-matched control subjects. In substudy B, CMR-TSI was assessed in relation to clinical events in 77 patients with HF and with a QRS > or =120 ms undergoing CRT.
RESULTS: In analysis A, CMR-TSI was higher in patients with HF and a QRS <120 ms (79.5 +/- 31.2 ms, p = 0.0003) and in those with a QRS > or =120 ms (105.9 +/- 55.8 ms, p < 0.0001) than in control subjects (21.2 +/- 8.1 ms). In analysis B, a CMR-TSI > or =110 ms emerged as an independent predictor of the composite end points of death or unplanned hospitalization for MCE (hazard ratio [HR] 2.45; 95% confidence interval [CI] 1.51 to 4.34, p = 0.0002) or death from any cause or unplanned hospitalization for HF (HR 2.15; 95% CI 1.23 to 4.14, p = 0.0060) as well as death from any cause (HR: 2.6; 95% CI 1.29 to 6.73, p = 0.0061) and cardiovascular death (HR 3.82; 95% CI 1.63 to 16.5, p = 0.0007) over a mean follow-up of 764 days.
CONCLUSIONS: Myocardial dyssynchrony assessed by CMR-TSI is a powerful independent predictor of mortality and morbidity after CRT.

Entities:  

Mesh:

Year:  2007        PMID: 17631217     DOI: 10.1016/j.jacc.2007.03.035

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  39 in total

Review 1.  Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy.

Authors:  Francisco Leyva; Paul W X Foley
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

2.  Maximum derivative of left ventricular pressure predicts cardiac mortality after cardiac resynchronization therapy.

Authors:  Hirohiko Suzuki; Masayuki Shimano; Yukihiko Yoshida; Yasuya Inden; Takashi Muramatsu; Yukiomi Tsuji; Naoya Tsuboi; Haruo Hirayama; Rei Shibata; Toyoaki Murohara
Journal:  Clin Cardiol       Date:  2010-12-08       Impact factor: 2.882

3.  Relationship of echocardiographic dyssynchrony to long-term survival after cardiac resynchronization therapy.

Authors:  John Gorcsan; Olusegun Oyenuga; Phillip J Habib; Hidekazu Tanaka; Evan C Adelstein; Hideyuki Hara; Dennis M McNamara; Samir Saba
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

4.  Method to create regional mechanical dyssynchrony maps from short-axis cine steady-state free-precession images.

Authors:  Jonathan D Suever; Brandon K Fornwalt; Lee R Neuman; Jana G Delfino; Michael S Lloyd; John N Oshinski
Journal:  J Magn Reson Imaging       Date:  2013-10-10       Impact factor: 4.813

Review 5.  Cardiac resynchronization therapy: the issue of non-response.

Authors:  Luigi Padeletti; Alessandro Paoletti Perini; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

6.  Quantitative analysis of intraventricular dyssynchrony using wall thickness by multidetector computed tomography.

Authors:  Quynh A Truong; Jagmeet P Singh; Christopher P Cannon; Ammar Sarwar; Khurram Nasir; Angelo Auricchio; Francesco F Faletra; Antonio Sorgente; Cristina Conca; Tiziano Moccetti; Mark Handschumacher; Thomas J Brady; Udo Hoffmann
Journal:  JACC Cardiovasc Imaging       Date:  2008-11

7.  Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy.

Authors:  F Leyva; P W X Foley; B Stegemann; J A Ward; L L Ng; M P Frenneaux; F Regoli; R E A Smith; A Auricchio
Journal:  Heart       Date:  2009-07-09       Impact factor: 5.994

Review 8.  Review of Journal of Cardiovascular Magnetic Resonance 2009.

Authors:  D J Pennell; D N Firmin; P J Kilner; W J Manning; R H Mohiaddin; S Neubauer; S K Prasad
Journal:  J Cardiovasc Magn Reson       Date:  2010-03-19       Impact factor: 5.364

Review 9.  Cardiac resynchronization therapy guided by cardiovascular magnetic resonance.

Authors:  Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-09       Impact factor: 5.364

10.  Radial dyssynchrony assessed by cardiovascular magnetic resonance in relation to left ventricular function, myocardial scarring and QRS duration in patients with heart failure.

Authors:  Paul W X Foley; Kayvan Khadjooi; Joseph A Ward; Russell E A Smith; Berthold Stegemann; Michael P Frenneaux; Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2009-11-24       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.